Waldencast plc WALD
Last close
0.88
2026-10-02
Market cap
$100.3M
estimated share count
52-week range
0.72 - 3.22
Valuation FY2025 figures against the last close
P/S0.4x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-2.01
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $272.1M | $273.9M | $218.1M | — | $142.5M | $94.4M | — |
| Cost of revenue | $89.1M | $82.1M | $76.6M | — | $55.0M | $29.1M | — |
| Gross profit | $183.0M | $191.7M | $141.6M | — | $87.4M | $65.3M | — |
| R&D | — | — | $3.2M | — | $6.1M | $4.4M | — |
| SG&A | $248.0M | $245.3M | $223.5M | — | $83.0M | $60.4M | — |
| Total operating expenses | $400.6M | $250.3M | $223.5M | — | $89.1M | $64.8M | — |
| Operating income | -$217.5M | -$58.6M | -$81.9M | — | -$1.6M | $528.0K | — |
| Interest expense | — | $17.2M | $18.9M | — | $11.1M | $6.3M | — |
| Pre-tax income | -$262.2M | -$48.5M | -$112.9M | — | -$10.0M | -$5.8M | — |
| Income tax | $14.2M | $110.0K | $7.0M | — | $9.6M | $3.4M | — |
| Net income | -$229.7M | -$42.4M | -$90.0M | — | -$19.6M | -$2.4M | — |
| EPS, basic | -2.01 | -0.39 | -0.99 | — | -2.45 | -0.30 | — |
| EPS, diluted | -2.01 | -0.39 | -0.99 | — | -2.45 | -0.30 | — |
| Shares, diluted (wtd. avg.) | 114.1M | 109.3M | 91.2M | — | 8.0M | 8.0M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $30.4M | $14.8M | $21.1M | $10.2M | $13.4M | $8.6M | $3.4M |
| Receivables | — | — | — | — | $18.7M | — | — |
| Inventory | $54.6M | $53.1M | $55.7M | $54.4M | $21.6M | — | — |
| Total current assets | $126.9M | $103.6M | $107.3M | $91.0M | $59.0M | $166.8K | — |
| Property, plant and equipment | $6.2M | $5.8M | $5.9M | $8.3M | $1.2M | — | — |
| Goodwill | $0 | $329.6M | $334.6M | $334.6M | $44.5M | $44.5M | — |
| Other intangibles | $427.1M | $526.4M | $582.9M | $639.2M | $79.6M | — | — |
| Total assets | $746.2M | $975.9M | $1.04B | $1.09B | $184.6M | $166.8K | — |
| Accounts payable | — | — | — | — | $12.7M | $177.7K | — |
| Short-term debt | $771.0K | $29.5M | $8.5M | $20.1M | $15.4M | — | — |
| Total current liabilities | $74.5M | $76.9M | $62.7M | $72.5M | $40.8M | $177.7K | — |
| Long-term debt | $135.8M | $137.1M | $151.3M | $159.2M | $103.4M | — | — |
| Total liabilities | $246.1M | $245.9M | $273.4M | $290.2M | $145.3M | $177.7K | — |
| Retained earnings | -$519.0M | -$289.2M | -$246.8M | -$156.8M | -$64.8M | -$11.0K | — |
| Total equity | $461.9M | $662.3M | $769.3M | $799.9M | $39.2M | -$11.0K | — |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$12.8M | -$8.8M | -$29.8M | — | $3.5M | -$7.4M | — |
| Depreciation and amortisation | $3.1M | $3.3M | $3.8M | — | $400.0K | $0 | — |
| Stock-based compensation | $11.8M | $9.4M | $9.2M | — | $0 | $0 | — |
| Capital expenditure | $3.4M | $2.7M | $1.6M | — | $424.0K | $1.1M | — |
| Investing cash flow | $76.2M | -$2.9M | -$2.0M | — | -$3.8M | -$1.7M | — |
| Financing cash flow | -$47.2M | $5.6M | $44.3M | — | $5.2M | $14.3M | — |
| Dividends paid | — | — | $0 | — | $2.0M | $2.0M | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001840199-26-000019.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | $94.4M | $142.5M | — | $218.1M | $273.9M | $272.1M |
| Gross profit | — | $65.3M | $87.4M | — | $141.6M | $191.7M | $183.0M |
| Net income | — | -$2.4M | -$19.6M | — | -$90.0M | -$42.4M | -$229.7M |
Others in SIC 2844
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| CL | COLGATE PALMOLIVE CO | $74.97B | 35.8x | 1.4% |
| EL | ESTEE LAUDER COMPANIES INC | $39.37B | 217.3x | 5.0% |
| KVUE | Kenvue Inc. | $37.59B | 25.8x | -2.1% |
| ELF | e.l.f. Beauty, Inc. | $6.74B | 259.6x | 24.6% |
| IPAR | INTERPARFUMS INC | $3.69B | 22.0x | 2.5% |
| COTY | COTY INC. | $2.84B | — | -1.5% |
| EPC | EDGEWELL PERSONAL CARE Co | $1.29B | 52.9x | -1.3% |
| SLSN | SOLESENCE, INC. | $56.5M | 40.0x | 18.6% |